MiR-132 provides neuroprotection for tauopathies via regulating the tau modifiers acetyltransferase EP300, kinase GSK3β, RNA-binding protein Rbfox1 and proteases Calpain2 and Caspases 3/7. Here, EP300 is linked to tauopathy.